Cao, Yu-Chen <br/><br/>
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.  [electronic resource] 

 -  Travel medicine and infectious disease   
 - 101647 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-0442 
<br/><br/><label>Standard No.: </label>10.1016/j.tmaid.2020.101647  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Monophosphate--analogs & derivatives<br/>Alanine--analogs & derivatives<br/>Angiotensin-Converting Enzyme 2<br/>Antiviral Agents--chemistry<br/>Betacoronavirus--chemistry<br/>COVID-19<br/>Clinical Trials as Topic<br/>Coronavirus Infections--drug therapy<br/>Genome, Viral--genetics<br/>Humans<br/>Pandemics<br/>Peptidyl-Dipeptidase A--chemistry<br/>Pneumonia, Viral--drug therapy<br/>SARS-CoV-2<br/>Spike Glycoprotein, Coronavirus--chemistry<br/>COVID-19 Drug Treatment